Our purpose is
to unlock the full potential of advanced therapies
DR. NICOLE FAUST
Chief Executive Officer
DR. Ulrich Kettling
Chief Business Officer
BOARD
DR. JOACHIM RAUTTER
Partner at PEPPERMINTVENTURE PARTNERS
Chairman of the Board
KARLHEINZ SCHMELIG
Managing Partner
at Creathor Venture
DR. ARISTOTELIS NASTOS
Head of Life Sciences
at NRW Bank Venture Fund
BART BERGSTEIN
Cofounder of Forbion Capital Partners
Former Life Science Venture Capitalist
DR. KLAUS ZIMMERMANN
Barrister-at-law
DR. ANDREA SCHILZ
Head of Business Development and
Project Management
at BioNTech IMFS GmbH
SCIENTIFIC ADVISORY BOARD
Dr. J. Fraser Wright
Professor of Pediatrics
Center for Definitive and Curative Medicine
Stanford University School of Medicine
Nicole K. Paulk, PhD
Assistant Professor University of California
San Francisco
PROF. DR. STEFAN KOCHANEK
Professor at the University of Ulm
and Director of the Department of Gene Therapy
DR. OTTO MERTEN
Specialist in gene therapy/vector manufacturing
Miltenyi Biotec
PROF. DR. JÜRGEN HUBBUCH
Professor at Karlsruhe Institute of Technology
Head of the Institute of Engineering in Life
Section IV: Biomolecular Separation Engineering
INVESTORS
GAT Holding (Switzerland), CEVEC’s management and further private investors are complementing the investor base of CEVEC Pharmaceuticals GmbH